Targeting RNA:protein interactions with an integrative approach leads to the identification of potent YBX1 inhibitors.
El Hage K, Babault N, Maciejak O, Desforges B, Craveur P, Steiner E, Rengifo-Gonzalez JC, Henrie H, Clement MJ, Joshi V, Bouhss A, Wang L, Bauvais C, Pastré D.
El Hage K, et al. Among authors: clement mj.
Elife. 2023 Jan 18;12:e80387. doi: 10.7554/eLife.80387.
Elife. 2023.
PMID: 36651723
Free PMC article.